13-110213718-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.279+64G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.232 in 1,530,950 control chromosomes in the GnomAD database, including 41,887 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 3878 hom., cov: 31)
Exomes 𝑓: 0.23 ( 38009 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.646

Publications

6 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-110213718-C-T is Benign according to our data. Variant chr13-110213718-C-T is described in ClinVar as Benign. ClinVar VariationId is 1258176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.279+64G>A
intron
N/ANP_001836.3
COL4A1
NM_001303110.2
c.279+64G>A
intron
N/ANP_001290039.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.279+64G>A
intron
N/AENSP00000364979.4
COL4A1
ENST00000543140.6
TSL:1
c.279+64G>A
intron
N/AENSP00000443348.1
COL4A1
ENST00000650424.2
c.279+64G>A
intron
N/AENSP00000497477.2

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34321
AN:
151886
Hom.:
3875
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.208
Gnomad AMI
AF:
0.455
Gnomad AMR
AF:
0.201
Gnomad ASJ
AF:
0.198
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.241
Gnomad OTH
AF:
0.244
GnomAD4 exome
AF:
0.232
AC:
320548
AN:
1378946
Hom.:
38009
AF XY:
0.231
AC XY:
159471
AN XY:
690680
show subpopulations
African (AFR)
AF:
0.210
AC:
6670
AN:
31832
American (AMR)
AF:
0.161
AC:
7160
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
0.189
AC:
4850
AN:
25604
East Asian (EAS)
AF:
0.296
AC:
11614
AN:
39244
South Asian (SAS)
AF:
0.181
AC:
15311
AN:
84542
European-Finnish (FIN)
AF:
0.204
AC:
10860
AN:
53280
Middle Eastern (MID)
AF:
0.193
AC:
981
AN:
5082
European-Non Finnish (NFE)
AF:
0.241
AC:
249745
AN:
1037352
Other (OTH)
AF:
0.232
AC:
13357
AN:
57580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
12405
24811
37216
49622
62027
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8250
16500
24750
33000
41250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.226
AC:
34345
AN:
152004
Hom.:
3878
Cov.:
31
AF XY:
0.225
AC XY:
16691
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.208
AC:
8637
AN:
41448
American (AMR)
AF:
0.200
AC:
3058
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.198
AC:
686
AN:
3472
East Asian (EAS)
AF:
0.308
AC:
1593
AN:
5170
South Asian (SAS)
AF:
0.184
AC:
887
AN:
4814
European-Finnish (FIN)
AF:
0.199
AC:
2103
AN:
10572
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.241
AC:
16387
AN:
67946
Other (OTH)
AF:
0.241
AC:
508
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1368
2736
4104
5472
6840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.224
Hom.:
2215
Bravo
AF:
0.226
Asia WGS
AF:
0.223
AC:
775
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.7
DANN
Benign
0.68
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3737328; hg19: chr13-110866065; COSMIC: COSV65422564; API